Literature DB >> 21948944

Interleukin 21 controls tumour growth and tumour immunosurveillance in colitis-associated tumorigenesis in mice.

Dominik Jauch1, Maria Martin, Gabriela Schiechl, Rebecca Kesselring, Hans Jürgen Schlitt, Edward K Geissler, Stefan Fichtner-Feigl.   

Abstract

BACKGROUND AND AIMS: Colitis-associated tumorigenesis is a balance between proliferation of tumour cells and tumour immunosurveillance. The role of T-helper-cell-derived cytokines in tumour growth is not fully understood. In this study the authors investigated the influence of interleukin (IL) 21 on intestinal tumorigenesis.
METHODS: Chronic colitis was induced in IL-21(-/-) and littermate control wild-type mice with three cycles of 1.5% dextran sulphate sodium (DSS) over 7 days followed by 7 days of drinking water. Mice received an azoxymethane injection on day 0 of DSS-colitis to induce tumorigenesis. Immunohistochemistry was performed on inflamed and tumour-bearing areas of colons. Cytokine expression of isolated colonic CD4 T cells was determined by ELISA. Cytotoxic capacity of isolated colonic CD8 T cells targeting tumour cells was evaluated by flow cytometry and quantitative cytotoxicity assay. Apoptosis of tumour cells was determined by TUNEL assay of colonic sections.
RESULTS: Increasing expression of IL-21 was observed in chronic colitis, which showed functional importance, since IL-21 deficiency prevented chronic DSS-colitis development. Further, in the absence of IL-21, significantly fewer tumour nodules were detected, despite a similar extent of intestinal inflammation. In wild-type mice, 8.6±1.9 tumour nodules were found compared with 1.0±1.2 in IL-21-deficient mice. In tumour-bearing IL-21-deficient mice, intestinal inflammation was restored and partly dependent on interferon (IFN)-γ, whereas the inflammation in wild-type mice showed high IL-17A concentrations. In these rare tumours in IL-21-deficient mice, tumour cell proliferation (Ki-67) was decreased, while cell apoptosis was increased, compared with wild-type mice. Increased IFNγ expression in tumour-bearing IL-21-deficient mice led to increased tumour immunosurveillance mediated by cytotoxic CD8CD103 T cells targeting E-cadherin(+) colonic tumour cells and therefore limited tumour growth.
CONCLUSION: These results indicate that IL-21 orchestrates colitis-associated tumorigenesis, leading to the hypothesis that high IFNγ and low IL-17A expression reduces tumour cell proliferation and increases tumour immunosurveillance.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21948944     DOI: 10.1136/gutjnl-2011-300612

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  30 in total

1.  Epidermal growth factor receptor inhibits colitis-associated cancer in mice.

Authors:  Philip E Dubé; Fang Yan; Shivesh Punit; Nandini Girish; Steven J McElroy; M Kay Washington; D Brent Polk
Journal:  J Clin Invest       Date:  2012-07-09       Impact factor: 14.808

Review 2.  Emerging cytokine networks in colorectal cancer.

Authors:  Nathan R West; Sarah McCuaig; Fanny Franchini; Fiona Powrie
Journal:  Nat Rev Immunol       Date:  2015-09-11       Impact factor: 53.106

Review 3.  Citrobacter rodentium: a model enteropathogen for understanding the interplay of innate and adaptive components of type 3 immunity.

Authors:  D J Silberger; C L Zindl; C T Weaver
Journal:  Mucosal Immunol       Date:  2017-06-14       Impact factor: 7.313

4.  Deficiency of the immunostimulatory cytokine IL-21 promotes intestinal neoplasia via dysregulation of the Th1/Th17 axis.

Authors:  Mia Shapiro; Bisweswar Nandi; Gabriel Gonzalez; Rao H Prabhala; Hiroshi Mashimo; Qin Huang; Natasha Y Frank; Nikhil C Munshi; Jason S Gold
Journal:  Oncoimmunology       Date:  2016-12-07       Impact factor: 8.110

Review 5.  Interleukin-21: a double-edged sword with therapeutic potential.

Authors:  Rosanne Spolski; Warren J Leonard
Journal:  Nat Rev Drug Discov       Date:  2014-04-22       Impact factor: 84.694

Review 6.  Recent advancement in understanding colitis-associated tumorigenesis.

Authors:  Daren Low; Mari Mino-Kenudson; Emiko Mizoguchi
Journal:  Inflamm Bowel Dis       Date:  2014-11       Impact factor: 5.325

Review 7.  Inflammation and colorectal cancer: colitis-associated neoplasia.

Authors:  Sergei I Grivennikov
Journal:  Semin Immunopathol       Date:  2012-11-16       Impact factor: 9.623

Review 8.  Immune responses triggering colitis and colitis-associated carcinoma.

Authors:  Rebecca Kesselring; Stefan Fichtner-Feigl
Journal:  Langenbecks Arch Surg       Date:  2012-03-01       Impact factor: 3.445

9.  Peritoneal carcinomatosis of colorectal cancer is characterized by structural and functional reorganization of the tumor microenvironment inducing senescence and proliferation arrest in cancer cells.

Authors:  Caroline Theresa Seebauer; Stefan Brunner; Gabriel Glockzin; Pompiliu Piso; Petra Ruemmele; Hans-Juergen Schlitt; Edward Kenneth Geissler; Stefan Fichtner-Feigl; Rebecca Kesselring
Journal:  Oncoimmunology       Date:  2016-10-14       Impact factor: 8.110

10.  Synergistic effects of soluble PD-1 and IL-21 on antitumor immunity against H22 murine hepatocellular carcinoma.

Authors:  Xiu-Cheng Pan; Li Li; Juan-Juan Mao; Wei Yao; Jun-Nian Zheng; Mei Liu; Juan-Juan Fu
Journal:  Oncol Lett       Date:  2012-10-12       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.